Combination chemotherapy with docetaxel and irinotecan in metastatic malignant melanoma.

Tas, FARUK; Camlica, H; Kurul, S; Aydiner, Adnan; Topuz, E

doi:10.1053/clon.2003.0205

Combination chemotherapy with docetaxel and irinotecan in metastatic malignant melanoma.

Tas F., Camlica H., Kurul S., Aydiner A., Topuz E.

Clinical oncology (Royal College of Radiologists (Great Britain)), cilt.15, sa.3, ss.132-5, 2003 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 15 Sayı: 3
Basım Tarihi: 2003
Doi Numarası: 10.1053/clon.2003.0205
Dergi Adı: Clinical oncology (Royal College of Radiologists (Great Britain))
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.132-5
İstanbul Üniversitesi Adresli: Evet

Özet

Aim: The aim of the current trial was to assess the efficacy and toxicity of 3-weekly intravenous docetaxel and irinotecan in the treatment of patients with metastatic malignant melanoma.